AHA 2021
AHA 2021
Advertisement
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial
DocWire News EditorsAHA 2021 | April 10, 2023
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared ...
Read More
Monitoring of Potential Atrial Fibrillation Triggers May Reduce Episodes
DocWire News EditorsAHA 2021 | April 12, 2023
Research findings from the I-STOP-AF Trial, presented at the American Heart Association’s Scientific Sessions 2021, ...
Read More
Very Few Adults With Heart Failure Enroll in Cardiac Rehab Despite Medicare Expansion
DocWire News EditorsAHA 2021 | April 10, 2023
A study, presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2021, ...
Read More
Illicit Substance Users Show Higher Risk of Developing Atrial Fibrillation
DocWire News EditorsAHA 2021 | November 12, 2021
According to an analysis of 10 years of medical data presented at the American Heart Association’s Scientific Sessions ...
Read More
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |